49.500
−1,00%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -9.4% | -44.9% | 0 / 3 | +0.3% | +0.01 pp | -0.35 pp | +3.7% | 0.22 | 108.13 | 576 | +0,3% | 11,4 | −14,9% | 108.13 | 79.28 | +36,4% |
| Pts | 0 | 0 | 0 | 0 | 8 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 49.500 (close price on 2026-10-19)EPS (TTM): 457,8
Financial charts
1.Revenue & growth
VND bn576Q2/26
1.Revenue & growth
VND bn576Q2/26
2.Profit & growth
VND bn11,9Q2/26
3.Profit mix (Penman)
VND bn53,4Q2/26
4.Margins & cost structure
%7.7%Q2/26
5.Returns & cash cycle
% · days1.4%Q2/26
6.Earnings quality & cash
VND bn127Q2/26
7.Asset structure
VND bn1.723Q2/26
8.Funding & debt health
VND bn · times1.723Q2/26
9.Revenue backlog
VND bn111Q2/26
10.Valuation
times · %111,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %132Q2/26
Adjusted EPS growth, latest quarter
-9.4%
Average adjusted EPS growth, 3 quarters
-44.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26